Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study

PURPOSE: Iodine-131—metaiodobenzylguanidine ((131)I-MIBG) provides targeted radiotherapy with more than 30% response rate in refractory neuroblastoma, but activity infused is limited by radiation safety and hematologic toxicity. The goal was to determine the maximum-tolerated dose of (131)I-MIBG in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matthay, Katherine K., Quach, Alekist, Huberty, John, Franc, Benjamin L., Hawkins, Randall A., Jackson, Hollie, Groshen, Susan, Shusterman, Suzanne, Yanik, Gregory, Veatch, Janet, Brophy, Patricia, Villablanca, Judith G., Maris, John M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2009
Materias:
Original Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738616/
https://ncbi.nlm.nih.gov/pubmed/19171714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.15.7628
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares